Yüklüyor......
Investigational EGFR-targeted therapies in HNSCC
IMPORTANCE OF THE FIELD: The epidermal growth factor receptor (EGFR) is an established therapeutic target in head and neck squamous cell carcinoma (HNSCC). The EGFR-targeting monoclonal antibody cetuximab (™Erbitux) was FDA-approved for use in HNSCC in 2006. The molecular basis for the efficacy of a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947445/ https://ncbi.nlm.nih.gov/pubmed/20415598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543781003769844 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|